Friday 6 November 2026 Export AVTR’s income statement to Excel — free account

Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue: +4.59%
EPS: +128.9%
Free cash flow: −9.03%
Total debt: −4.51%

Quarter to September 2026, against a year earlier

Insider buying

15.14 0.51 −3.26%

Follow AVTR

Alert me

Market cap: $10.3B
P/E: 30.3×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.55
Beneish M: −2.91
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Avantor, Inc. (AVTR) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2024: revenue by segment, and margins
Laboratory Solutions	4,610	67.96%
Bioscience Production	2,174	32.04%
Gross margin		33.60%
Operating margin		15.99%
Pre-tax margin		12.59%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Proprietary	3,449 52.64%	3,615 53.29%	3,720 53.40%	4,025 53.57%	2,548 34.50%	2,044 31.96%	1,765 29.23%	1,688 28.79%
Third-party	3,103 47.36%	3,169 46.71%	3,247 46.60%	3,488 46.43%	2,906 39.35%	2,672 41.79%	2,584 42.77%	2,571 43.84%
Equipment And Instrumentation	—	—	—	—	1,009 13.66%	861 13.46%	912 15.11%	909 15.50%
Services And Specialty Procurement	—	—	—	—	923 12.49%	818 12.79%	779 12.90%	696 11.87%
Revenue	6,552	6,784	6,967	7,512	7,386	6,394	6,040	5,864

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Laboratory Solutions	4,400 67.15%	4,610 67.96%	4,738 68.01%	5,002 66.59%	—	—	—	—	—
Bioscience Production	2,153 32.85%	2,174 32.04%	2,229 31.99%	2,510 33.41%	—	—	—	—	—
Americas	—	—	—	—	4,237 57.37%	3,732 58.36%	3,585 59.35%	3,461 59.02%	688 55.16%
Europe	—	—	—	—	2,677 36.25%	2,287 35.77%	2,102 34.80%	2,095 35.73%	381 30.58%
Amea	—	—	—	—	471 6.38%	375 5.87%	354 5.85%	308 5.25%	178 14.26%
Corporate, Non-Segment	—	—	—	—	—	—	—	—	0 0.00%
Revenue	6,552	6,784	6,967	7,512	7,386	6,394	6,040	5,864	1,247

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Organic net sales growth	Q3 FY2026	5.20%	—	—

	Q3 FY2026	Q2 FY2025	Q1 FY2025	Q4 FY2024
Organic net sales growth	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.